Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage: An Experimental Animal Study

May 2019 in “ International Journal of Environmental Research and Public Health ”

Mirza Wasif Baig, Agnieszka Kolasa, Anna Pilutin, Krzysztof Safranow, Irena Baranowska-Bosiacka, Joanna Kabat-Koperska, Barbara Wiszniewska

finasteride 5α-reductase type 2 androgen receptor intracellular junctional proteins DHT androgen supplementation renal dysfunction renal transplantation Propecia dihydrotestosterone kidney disease

TLDR Finasteride may cause kidney damage.

The study investigated the effects of finasteride, a drug used to treat hair loss, on the kidneys of male rats. The researchers found that finasteride treatment led to a decrease in androgen receptor expression and changes in intracellular junctional proteins, which were associated with pathomorphological changes in the rats' kidneys. The study suggests that patients with renal dysfunction or following renal transplantation with androgen supplementation or with pharmacologically induced DHT deficiency should be under special control and covered by extended diagnostics due to the potential adverse effect of DHT deficiency on the progression of kidney disease.

View this study on mdpi.com →

Discuss this study in the Community →

Cited in this study

9 / 9 results

research Connexin 43 Expression in the Testes During Postnatal Development of Finasteride-Treated Male Rat Offspring

3 citations , November 2016 in “Archives of Medical Science”

Finasteride treatment changes Cx43 in rat testes, possibly causing fertility issues.

research Androgen Levels and Apoptosis in the Testis During Postnatal Development of Finasteride-Treated Male Rat Offspring

10 citations , January 2015 in “Folia Histochemica Et Cytobiologica”

research Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells

25 citations , February 2009 in “The Journal of Urology”

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

research Exogenous Testosterone Alone or With Finasteride Does Not Improve Measurements of Cognition in Healthy Older Men With Low Serum Testosterone

77 citations , November 2007 in “International Journal of Andrology”

Testosterone with or without finasteride doesn't improve thinking skills in older men with low testosterone.

research Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone

417 citations , February 2004 in “The Journal of Clinical Endocrinology and Metabolism”

Testosterone therapy increases bone density in older men with low testosterone levels.

research Long-Term Multinational Experience with Finasteride 1 mg in the Treatment of Men with Androgenetic Alopecia

20 citations , January 2002 in “PubMed”

Finasteride 1 mg/day for five years effectively improves hair growth and slows hair loss in men with male pattern baldness, and is safe for long-term use.

research Contribution of Androgens to Chronic Allograft Nephropathy Is Mediated by Dihydrotestosterone

25 citations , November 2001 in “Kidney International”

Male hormones worsen kidney transplant damage, but blocking them helps.

research Finasteride

125 citations , January 1999 in “Drugs”

Finasteride effectively treats baldness but may cause sexual side effects.

research Finasteride

86 citations , July 1993 in “Drugs”

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

1 / 1 results

research Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men.

30 citations , August 1992 in “The Journal of Clinical Endocrinology and Metabolism”

Finasteride doesn't affect hormone levels in normal men.